Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
25 March 2022Website:
http://www.an2therapeutics.comNext earnings report:
09 August 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | Tue, 02 Jul 2024 13:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
ANTX Latest News
AN2 Therapeutics, Inc. (ANTX) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
AN2 Therapeutics, Inc. (ANTX) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, today announced two oral presentations and three poster presentations at the Infectious Disease Society of America (IDSA) IDWeek 2023 Conference from October 11-15, 2023 in Boston, Massachusetts. AN2 Therapeutics is currently enrolling patients in the Phase 3 part of its p.
Here is how AN2 Therapeutics, Inc. (ANTX) and Artivion (AORT) have performed compared to their sector so far this year.
AN2 is a developer of rare, infectious disease therapeutics. AN2 leverages its boron chemistry expertise and has a history of a successful sale to Pfizer.
What type of business is AN2 Therapeutics?
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.
What sector is AN2 Therapeutics in?
AN2 Therapeutics is in the Healthcare sector
What industry is AN2 Therapeutics in?
AN2 Therapeutics is in the Biotechnology industry
What country is AN2 Therapeutics from?
AN2 Therapeutics is headquartered in United States
When did AN2 Therapeutics go public?
AN2 Therapeutics initial public offering (IPO) was on 25 March 2022
What is AN2 Therapeutics website?
https://www.an2therapeutics.com
Is AN2 Therapeutics in the S&P 500?
No, AN2 Therapeutics is not included in the S&P 500 index
Is AN2 Therapeutics in the NASDAQ 100?
No, AN2 Therapeutics is not included in the NASDAQ 100 index
Is AN2 Therapeutics in the Dow Jones?
No, AN2 Therapeutics is not included in the Dow Jones index
When does AN2 Therapeutics report earnings?
The next expected earnings date for AN2 Therapeutics is 09 August 2024